Teva-Efavirenz/Emtricitabine/Tenofovir 300 mg (Tenofovir Disoproxil Fumarate TABLET) 300 MG

Teva-Efavirenz/Emtricitabine/Tenofovir 300 mg tablets are a combination medication used in HIV treatment. This oral tablet contains efavirenz, emtricitabine, and tenofovir disoproxil fumarate, manufactured by Teva Canada Limited.

Strength

300 MG

Pack Size

Manufacturer / TM Owner

TEVA CANADA LIMITED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Teva-Efavirenz/Emtricitabine/Tenofovir 300 mg tablets are commonly used as part of antiretroviral therapy (ART) to manage HIV infection. This combination medication helps control the virus, reducing its ability to replicate in the body. It is often prescribed to adults and adolescents as a part of a comprehensive treatment plan.

Side Effects

Common effects of Teva-Efavirenz/Emtricitabine/Tenofovir 300 mg tablets may include dizziness, nausea, and headache. Some individuals might experience fatigue or unusual dreams. These effects can vary from person to person and may subside as the body adjusts to the medication.

Precautions & Warnings

It is important to follow the advice of a healthcare provider when taking Teva-Efavirenz/Emtricitabine/Tenofovir 300 mg tablets. This medication should be stored at room temperature and kept out of reach of children. Regular monitoring and follow-up appointments are recommended to ensure the medication's effectiveness and safety.

Avoid Interactions

Teva-Efavirenz/Emtricitabine/Tenofovir 300 mg tablets may interact with other medications, including certain antacids, antibiotics, and antifungal drugs. Alcohol consumption should be avoided as it can increase the risk of side effects. Always inform your healthcare provider about all medications and supplements you are taking.

Frequently Asked Questions

Teva-Efavirenz/Emtricitabine/Tenofovir 300 mg tablets are used as part of antiretroviral therapy to manage HIV infection.

Store Teva-Efavirenz/Emtricitabine/Tenofovir 300 mg tablets at room temperature, away from moisture and heat.

Common side effects may include dizziness, nausea, headache, fatigue, and unusual dreams.

It is advisable to avoid alcohol while taking Teva-Efavirenz/Emtricitabine/Tenofovir 300 mg tablets.

If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.